Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Rogler

Showing results (91-100 of 547) with videos related to

Pageof 55
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 20, 2007
Sexual function in persons with inflammatory bowel disease: a survey with matched controlsAntje Timmer, Alexandra Bauer, Axel Dignass, et al.
Inflammatory Intestinal Diseases|July 19, 2018
The Efficacy and Safety of Golimumab as Third- or Fourth-Line Anti-TNF Therapy in Patients with Refractory Crohn's Disease: A Case SeriesLinda Russi, Michael Scharl, Gerhard Rogler, et al.
Gastroenterology|August 6, 2021
Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease ManagementGerhard Rogler, Abha Singh, Arthur Kavanaugh, et al.
World Journal of Gastroenterology|November 28, 2013
Mucosal healing and deep remission: what does it mean?Gerhard Rogler, Stephan Vavricka, Alain Schoepfer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 7, 2014
Pushing the pedal to the metal: should we accelerate infliximab therapy for patients with severe ulcerative colitis?Hans H Herfarth, Gerhard Rogler, Peter D R Higgins
World Journal of Gastroenterology|March 8, 2013
Use of thiopurines in inflammatory bowel diseasePascal Frei, Luc Biedermann, Ole Haagen Nielsen, et al.
Expert Review of Gastroenterology & Hepatology|August 8, 2014
The role and advances of immunomodulator therapy for inflammatory bowel diseaseOle Haagen Nielsen, Mehmet Coskun, Casper Steenholdt, et al.
Current Drug Targets|September 9, 2014
Biologics for extraintestinal manifestations of IBDStephan R Vavricka, Michael Scharl, Martin Gubler, et al.
Digestion|September 15, 2010
Dying in yoghurt: the number of living bacteria in probiotic yoghurt decreases under exposure to room temperatureMichael Scharl, Steffen Geisel, Stephan R Vavricka, et al.
JMIR Research Protocols|June 12, 2023
The Efficacy of a Diet Low in Fermentable Oligo-, Di-, Monosaccharides, and Polyols in Irritable Bowel Syndrome Compared to Its "Real-world" Effectiveness: Protocol for a Systematic ReviewSandra Jent, Natalie Sara Bez, Loan Catalano, et al.
Pageof 55

Showing results (91-100 of 547) with videos related to

Sort By:
Pageof 55
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 20, 2007
Sexual function in persons with inflammatory bowel disease: a survey with matched controlsAntje Timmer, Alexandra Bauer, Axel Dignass, et al.
Inflammatory Intestinal Diseases|July 19, 2018
The Efficacy and Safety of Golimumab as Third- or Fourth-Line Anti-TNF Therapy in Patients with Refractory Crohn's Disease: A Case SeriesLinda Russi, Michael Scharl, Gerhard Rogler, et al.
Gastroenterology|August 6, 2021
Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease ManagementGerhard Rogler, Abha Singh, Arthur Kavanaugh, et al.
World Journal of Gastroenterology|November 28, 2013
Mucosal healing and deep remission: what does it mean?Gerhard Rogler, Stephan Vavricka, Alain Schoepfer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 7, 2014
Pushing the pedal to the metal: should we accelerate infliximab therapy for patients with severe ulcerative colitis?Hans H Herfarth, Gerhard Rogler, Peter D R Higgins
World Journal of Gastroenterology|March 8, 2013
Use of thiopurines in inflammatory bowel diseasePascal Frei, Luc Biedermann, Ole Haagen Nielsen, et al.
Expert Review of Gastroenterology & Hepatology|August 8, 2014
The role and advances of immunomodulator therapy for inflammatory bowel diseaseOle Haagen Nielsen, Mehmet Coskun, Casper Steenholdt, et al.
Current Drug Targets|September 9, 2014
Biologics for extraintestinal manifestations of IBDStephan R Vavricka, Michael Scharl, Martin Gubler, et al.
Digestion|September 15, 2010
Dying in yoghurt: the number of living bacteria in probiotic yoghurt decreases under exposure to room temperatureMichael Scharl, Steffen Geisel, Stephan R Vavricka, et al.
JMIR Research Protocols|June 12, 2023
The Efficacy of a Diet Low in Fermentable Oligo-, Di-, Monosaccharides, and Polyols in Irritable Bowel Syndrome Compared to Its "Real-world" Effectiveness: Protocol for a Systematic ReviewSandra Jent, Natalie Sara Bez, Loan Catalano, et al.
Pageof 55